Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Crump, Michael; Kuruvilla, John; Couban, Stephen; MacDonald, David; Kukreti, Vishal; Tom Kouroukis, C.; Rubinger, Morel; Buckstein, Rena; Imrie, Kevin; Federico, Massimo; Di Renzo, Nicola; Howson‐Jan, Kang; Baetz, Tara; Kaizer, Leonard; Voralia, Michael; J. Olney, Harold; Robert Turner, A.; Sussman, Jonathan; E. Hay, Annette; Djurfeldt, Marina; M. Meyer, Ralph; E. Chen, Bingshu; E. Shepherd, Lois

doi:10.1200/jco.2013.53.9593

Public

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Published in Journal of Clinical Oncology • Sep 29, 2014

Authors:

Michael Crump

John Kuruvilla

Stephen Couban

Abstract

PURPOSE: For patients with relapsed or refractory aggressive lymphoma, we hypothesized that gemcitabine-based therapy before autologous stem-cell transplantation (ASCT) is as effective as and less toxic than standard treatment. PATIENTS AND METHODS: We randomly assigned 619 patients with relapsed/re...

Subject

Medicine

Gemcitabine

DHAP

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!